PharmTech News

Articles

Novo Nordisk plans to invest approximately $2 billion over the next five years in new production facilities in Clayton, North Carolina, US and Måløv, Denmark. The facilities are expected to be operational during 2020.

Novo Nordisk Unveils Plans to Boost Manufacturing Capacity in North Carolina and Denmark

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

The drug was the first PCSK9 inhibitor approved in Europe and the second approved in the US.

FDA Approves Amgen’s PCSK9 Inhibitor Repatha

GSK announces plan to divest its rights in ofatumumab for auto-immune indications for up to $1 billion.

Novartis Pharma Acquires Rights to Ofatumumab

The TRUST project will focus on the process development of Col-Treg, which is TxCell’s autologous collagen type II specific Treg immunotherapy product for the treatment of autoimmune uveitis.

TxCell Consortium Receives EUR 1.28 Million Funding for Immunotherapy Project

Merus announced new investors and the sale of $80.5 million in shares to advance its immuno-oncology programs.

Merus Obtains Financing and Progresses in Clinical Trials of Bispecific Antibodies

Pfizer agrees to divest four sterile injectable assets to clear the way to complete acquisition of Hospira.

Pfizer Receives FTC Clearance for Hospira Acquisition

Shire requests a technical transfer from Sanquin to widen its manufacturer base for the production of Cinryze.

Shire to Add Manufacturing Capacity for Cinryze

Allergan issued a voluntary nationwide recall in the US of specific lots of ophthalmic ointment after customers complained of black particles, which came from the cap.

Allergan Recalls Eye Medication Due to Cap Particles

Biopharmaceutical company BeiGene plans to build facility in Suzhou to expand its clinical capability and prepare for commercial manufacturing.

BeiGene Plans First cGMP Manufacturing Facility in Suzhou, China

Mylan received a warning letter citing violations at its Agila Specialty Formulation Facility, Sterile Products Division, and Onco Therapies Limited sites in India.

Bio/Pharma News